Original Research
Copyright ©The Author(s) 1997.
World J Gastroenterol. Jun 15, 1997; 3(2): 64-66
Published online Jun 15, 1997. doi: 10.3748/wjg.v3.i2.64
Figure 1
Figure 1 Clear cell hepatocellular carcinoma. HE × 400.
Figure 2
Figure 2 Giant cell hepatocellular carcinoma. HE × 400.
Figure 3
Figure 3 Spindle cell hepatocellular carcinoma. HE × 400.
Figure 4
Figure 4 Clear cell hepatocellular carcinoma. The AFP-positive portion in clear cells was expressed in the periphery of the cytoplasm. Immunohistochemical stains × 400. AFP: Alpha-fetoprotein.
Figure 5
Figure 5 Clear cell hepatocellular carcinoma. The AAT-positive portion was expressed in the cytoplasm. Immunohistochemical stains × 100. AAT: Alpha-1-antitrypsin.
Figure 6
Figure 6 Clear cell hepatocellular carcinoma. The EMA-positive portion was expressed in the cancer cell membrane. Immunohistochemical stains × 100. EMA: Epithelial membrane antigen.
Figure 7
Figure 7 Clear cell hepatocellular carcinoma. Tests for vimentin expression in cancer cells were negative, but those in the interstitial tissues appear to be positive. Immunohistochemical stains × 100